Scientific Advisory Committee on Medical Devices used in Cardiovascular System - Agenda - November 28, 2014
Place: Holland Cross, Tower B, Room 2048
Date and time: November 28, 2014, 7:30 am to 16:00pm
Chairperson: Dr. John Ducas
Science Advisor: Hripsime Shahbazian
Participants: SAC MDUCS Members, Health Canada
Scientific & Regulatory Officers: Caroline Hunt
7:30-8:00
Refreshments
8:00-8:10
Opening Remarks: Review of the Agenda, Declaration of Affiliations and Interest.
Barbara J Sabourin (DGO,TPD) & Dr. John Ducas (SAC-MDUCS Chair)
8:10-8:25
Summary of how Information from Previous Meetings is Being Used Mr. Kevin Day (Medical Devices Bureau, TPD)
8:25-10:10
Question 1: Renal Denervation - Next Steps for a Regulatory Body, Typical Use, Requirements for New Licenses Speaker: Dr. Raj Padwal
10:10-10:25
Break
10:25-11:25
Question 2: Use of LAA Closure Devices, Clinical Requirements and Patient Populations Speaker: Dr. Réda Ibrahim
11:25-12:10
Question 3: TAVI - Clinically Significant Technological Features Speaker: Dr. John Webb (Committee Member)
12:10-1:00
Lunch
1:00-2:30
Question 4: Aortic Dissection Speakers: Dr. Thomas Forbes and Dr. Prasad Jetty
2:30-3:15
Question 5: Intracompatibility between IS-4 Leads and Cans Speaker: Dr. Raymond Yee (Committee Member)
3:15-3:55
Late Breaking Issues in Cardiovascular Devices Bioabsorbable Vascular Scaffolds and Their Appropriate Patient Populations (Committee Discussion - Introduction by Dr. Ian Aldous)
Responses to dual antiplatelet therapy duration clinical trial results from AHA (Committee Discussion - Introduction by Kevin Day)
3:55-4:00
Next Steps, Closing Remarks and Adjournment of Meeting
